Drug-induced taste disorders

Drug Safety

Volumn 31, Issue 3, 2008, Pages 199-215

  Doty, Richard L ^a   Shah, Muhammad ^a   Bromley, Steven M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Anesthesiology   (United States)

Author keywords

ACE inhibitors, adverse reactions; Angiotensin II receptor antagonists, adverse reactions; Antibacterials, adverse reactions; Antidepressants, adverse reactions; Antiepileptic drugs, adverse reactions; Antifungals, adverse reactions

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMPICILLIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIMETABOLITE; ANTITHYROID AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; AZITHROMYCIN; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLURAZEPAM; HYPNOTIC AGENT; METRONIDAZOLE; MOOD STABILIZER; NEUROLEPTIC AGENT; TRANQUILIZER; UNINDEXED DRUG;

AGE; BODY MASS; CANDIDIASIS; DENTAL CARIES; DIABETES MELLITUS; DIETARY INTAKE; DISEASE PREDISPOSITION; DYSGEUSIA; EMOTION; EPILEPTIC AURA; GENETIC VARIABILITY; GLOSSITIS; HALLUCINATION; HUMAN; HYPERTENSION; INCIDENCE; INFECTION; NEOPLASM; NONHUMAN; ORAL BLEEDING; PATIENT COMPLIANCE; PATIENT COUNSELING; PERIODONTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEIZURE; SEX DIFFERENCE; SIMPLE PARTIAL SEIZURE; SMELLING DISORDER; STOMATITIS; TASTE ACUITY; TASTE DISORDER; THRUSH; TOOTH DISEASE;

EID: 39749134742     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831030-00002     Document Type: Review

References (124)

1. 1. J Guggenheimer 2002 Oral manifestations of drug therapy Dent Clin North Am 46 4 857 68 12436836 10.1016/S0011-8532(02)00024-1 Guggenheimer J. Oral manifestations of drug therapy. Dent Clin North Am 2002; 46(4): 857–68
2. 2. HM Marks 1995 Revisiting the origins of compulsory drug prescriptions Am J Public Health 85 1 109 15 7832245 1:STN:280:DyaK2M7jtlKnsw%3D%3D 10.2105/AJPH.85.1.109 Marks HM. Revisiting the origins of compulsory drug prescriptions. Am J Public Health 1995; 85(1): 109–15
3. 3. SG Ciancio 2004 Medications’ impact on oral health J Am Dent Assoc 135 10 1440 8 15551986 Ciancio SG. Medications’ impact on oral health. J Am Dent Assoc 2004; 135(10): 1440–8
4. 4. Physicians’ Desk Reference. Montvale (NJ): Medical Economics Company, Inc., 2005
5. 5. IK Lewis JT Hanlon MJ Hobbins 1993 Use of medications with potential oral adverse drug reactions in community-dwelling elderly Spec Care Dentist 13 4 171 6 8303513 1:STN:280:DyaK2c7jsFGiuw%3D%3D 10.1111/j.1754-4505.1993.tb01470.x Lewis IK, Hanlon JT, Hobbins MJ, et al. Use of medications with potential oral adverse drug reactions in community-dwelling elderly. Spec Care Dentist 1993; 13(4): 171–6
6. 6. RS Shinkai JP Hatch CB Schmidt 2006 Exposure to the oral side effects of medication in a community-based sample Spec Care Dentist 26 3 116 20 16774189 10.1111/j.1754-4505.2006.tb01434.x Shinkai RS, Hatch JP, Schmidt CB, et al. Exposure to the oral side effects of medication in a community-based sample. Spec Care Dentist 2006; 26(3): 116–20
7. 7. G Ahne A Erras T Hummel 2000 Assessment of gustatory function by means of tasting tablets Laryngoscope 110 8 1396 401 10942148 1:STN:280:DC%2BD3cvgs1Wrsw%3D%3D 10.1097/00005537-200008000-00033 Ahne G, Erras A, Hummel T, et al. Assessment of gustatory function by means of tasting tablets. Laryngoscope 2000 Aug; 110(8): 1396–401
8. 8. RL Doty 2007 Office procedures for quantitative assessment of olfactory function Amer J Rhinol 21 4 460 73 10.2500/ajr.2007.21.3043 Doty RL. Office procedures for quantitative assessment of olfactory function. Amer J Rhinol 2007; 21(4): 460–73
9. 9. DA Deems RL Doty RG Settle 1991 Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center Arch Otolaryngol Head Neck Surg 117 5 519 28 2021470 1:STN:280:DyaK3M3hsVKnuw%3D%3D 10.1001/archotol.1991.01870170065015 Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 1991; 117(5): 519–28
10. 10. KJ Burdach RL Doty 1987 The effects of mouth movements, swallowing, and spitting on retronasal odor perception Physiol Behav 41 4 353 6 3432387 1:STN:280:DyaL1c7isFCjsw%3D%3D 10.1016/0031-9384(87)90400-8 Burdach KJ, Doty RL. The effects of mouth movements, swallowing, and spitting on retronasal odor perception. Physiol Behav 1987; 41(4): 353–6
11. 11. BE Byrne 2006 Oral manifestations of systemic agents SG Ciancio ADA®/PDR® guide to dental therapeutics 4th Thomson PDR Montvale (NJ) 835 9 Byrne BE. Oral manifestations of systemic agents. In: Ciancio SG, editor. ADA®/PDR® guide to dental therapeutics. 4th ed. Montvale (NJ): Thomson PDR, 2006: 835–9
12. 12. HR Keiser RI Henkin FC Bartter 1968 Loss of taste during therapy with penicillamine JAMA 203 6 381 3 5694119 1:STN:280:DyaF1c7gtlSjsA%3D%3D 10.1001/jama.1968.03140060005002 Keiser HR, Henkin RI, Bartter FC, et al. Loss of taste during therapy with penicillamine. JAMA 1968; 203(6): 381–3
13. 13. L Fogan 2007 Griseofulvin and dysgeusia: implications? Ann Intern Med 74 795 6 Fogan L. Griseofulvin and dysgeusia: implications? Ann Intern Med 2007; 74: 795–6
14. 14. SM Bromley RL Doty 2003 Clinical disorders affecting taste: evaluation and management RL Doty Handbook of olfaction and gustation Marcel Dekker New York 935 57 Bromley SM, Doty RL. Clinical disorders affecting taste: evaluation and management. In: Doty RL, editor. Handbook of olfaction and gustation. New York: Marcel Dekker, 2003: 935–57
15. 15. T Ishizaka Y Miyanaga J Mukai 2004 Bitterness evaluation of medicines for pediatric use by a taste sensor Chem Pharm Bull 52 8 943 8 15304986 1:CAS:528:DC%2BD2cXmvVKkur8%3D 10.1248/cpb.52.943 Ishizaka T, Miyanaga Y, Mukai J, et al. Bitterness evaluation of medicines for pediatric use by a taste sensor. Chem Pharm Bull 2004; 52(8): 943–8
16. 16. SS Schiffman J Zervakis HL Westall 2000 Effect of antimicrobial and anti-inflammatory medications on the sense of taste Physiol Behav 69 4–5 413 24 10913779 1:CAS:528:DC%2BD3cXltVGqt7c%3D 10.1016/S0031-9384(99)00262-0 Schiffman SS, Zervakis J, Westall HL, et al. Effect of antimicrobial and anti-inflammatory medications on the sense of taste. Physiol Behav 2000; 69(4–5): 413–24
17. 17. L Juhlin 1992 Loss of taste and terbinafine [letter] Lancet 339 8807 1483 1351157 1:STN:280:DyaK383pt1Oqtw%3D%3D 10.1016/0140-6736(92)92081-P Juhlin L. Loss of taste and terbinafine [letter]. Lancet 1992; 339(8807): 1483
18. 18. M Beutler K Hartmann M Kuhn 1993 Taste disorders and terbinafine [letter] BMJ 307 26 8343667 1:STN:280:DyaK3szksVKmuw%3D%3D 10.1136/bmj.307.6895.26-b Beutler M, Hartmann K, Kuhn M, et al. Taste disorders and terbinafine [letter]. BMJ 1993: 307: 26
19. 19. JL Bong TW Lucke CD Evans 1998 Persistent impairment of taste resulting from terbinafine Br J Dermatol 139 4 747 8 9892929 1:STN:280:DyaK1M7htFehtw%3D%3D 10.1046/j.1365-2133.1998.02485.x Bong JL, Lucke TW, Evans CD. Persistent impairment of taste resulting from terbinafine. Br J Dermatol 1998; 139(4): 747–8
20. 20. RL Doty BR Haxel 2005 Objective assessment of terbinafine-induced taste loss Laryngoscope 115 11 2035 7 16319619 1:CAS:528:DC%2BD2MXht1GksrnI 10.1097/01.MLG.0000181462.08683.0C Doty RL, Haxel BR. Objective assessment of terbinafine-induced taste loss. Laryngoscope 2005; 115(11): 2035–7
21. 21. BH Stricker RM Van MC Sturkenboom 1996 Taste loss to terbinafine: a case-control study of potential risk factors Br J Clin Pharmacol 42 3 313 8 8877021 1:CAS:528:DyaK28XlvVGntrw%3D 10.1046/j.1365-2125.1996.04105.x Stricker BH, Van RM, Sturkenboom MC, et al. Taste loss to terbinafine: a case-control study of potential risk factors. Br J Clin Pharmacol 1996; 42(3): 313–8
22. 22. EM Granger JI Glendinning JC Smith 1993 Behavioral and electrophysiological responses to NaCl in young and old fisch-er-344 rats Chem Senses 18 4 419 26 1:CAS:528:DyaK3sXmt1amurs%3D 10.1093/chemse/18.4.419 Granger EM, Glendinning JI, Smith JC, et al. Behavioral and electrophysiological responses to NaCl in young and old fisch-er-344 rats. Chem Senses 1993; 18(4): 419–26
23. 23. JA Balfour D Faulds 1992 Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses Drugs 43 2 259 84 1372222 1:CAS:528:DyaK38XitVOhsLg%3D 10.2165/00003495-199243020-00010 Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43(2): 259–84
24. 24. RL Doty S Philip K Reddy 2003 Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review J Hypertens 21 10 1805 13 14508182 1:CAS:528:DC%2BD3sXnsFSgurc%3D 10.1097/00004872-200310000-00003 Doty RL, Philip S, Reddy K, et al. Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. J Hypertens 2003; 21(10): 1805–13
25. 25. G Hellekant V Danilova Y Ninomiya 1997 Primate sense of taste: behavioral and single chorda tympani and glossopharyngeal nerve fiber recordings in the rhesus monkey, Macaca mulatta J Neurophysiol 77 2 978 93 9065862 1:STN:280:DyaK2s3hvVChtw%3D%3D Hellekant G, Danilova V, Ninomiya Y. Primate sense of taste: behavioral and single chorda tympani and glossopharyngeal nerve fiber recordings in the rhesus monkey, Macaca mulatta. J Neurophysiol 1997; 77(2): 978–93
26. 26. DA Eiznhamer T Creagh JL Ruckle 2002 Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers HIV Clin Trials 3 6 435 50 12501127 10.1310/9GDE-F2R1-W2RL-E9FJ Eiznhamer DA, Creagh T, Ruckle JL, et al. Safety and pharmacokinetic profile of multiple escalating doses of (+)-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers. HIV Clin Trials 2002; 3(6): 435–50
27. 27. MO Johnson T Stallworth TB Neilands 2003 The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART AIDS Behav 7 2 109 17 14586196 10.1023/A:1023938023005 Johnson MO, Stallworth T, Neilands TB. The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav 2003; 7(2): 109–17
28. 28. S Eksborg N Pal M Kalin 2002 Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir? Med Pediatr Oncol 38 4 240 6 11920787 10.1002/mpo.1317 Eksborg S, Pal N, Kalin M, et al. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir? Med Pediatr Oncol 2002; 38(4): 240–6
29. 29. FG Hayden K Andries PA Janssen 1992 Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection Antimicrob Agents Chemother 36 4 727 32 1503435 1:STN:280:DyaK38zmvVWlug%3D%3D 10.1128/AAC.36.4.727 Hayden FG, Andries K, Janssen PA. Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob Agents Chemother 1992; 36(4): 727–32
30. 30. PH Hsyu YK Pithavala M Gersten 2002 Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers Antimicrob Agents Chemother 46 2 392 7 11796347 1:CAS:528:DC%2BD38XosFyisw%3D%3D 10.1128/AAC.46.2.392-397.2002 Hsyu PH, Pithavala YK, Gersten M, et al. Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. Antimicrob Agents Chemother 2002; 2002 Feb; 46(2): 392–7
31. 31. LH Wang RW Peck Y Yin 2003 Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytome-galovirus agent, in healthy and human immunodeficiency virus-infected subjects Antimicrob Agents Chemother 47 4 1334 42 12654667 1:CAS:528:DC%2BD3sXivVSmsr0%3D 10.1128/AAC.47.4.1334-1342.2003 Wang LH, Peck RW, Yin Y, et al. Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytome-galovirus agent, in healthy and human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother 2003; 47(4): 1334–42
32. 32. ML Macknin M Piedmonte C Calendine 1998 Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial JAMA 279 24 1962 7 9643859 1:CAS:528:DyaK1cXksFelsLs%3D 10.1001/jama.279.24.1962 Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA 1998; 279(24): 1962–7
33. 33. S Marshall 1998 Zinc gluconate and the common cold. Review of randomized controlled trials Can Fam Phy 44 1037 42 1:STN:280:DyaK1c3nsFGgtA%3D%3D Marshall S. Zinc gluconate and the common cold. Review of randomized controlled trials. Can Fam Phy 1998; 44: 1037–42
34. 34. SB Mossad ML Macknin SV Medendorp 1996 Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study Ann Intern Med 125 2 81 8 8678384 1:CAS:528:DyaK28XkslelsL4%3D Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study. Ann Intern Med 1996; 125(2): 81–8
35. 35. Tanaka M. Secretory function of the salivary gland in patients with taste disorders or xerostomia: correlation with zinc deficiency. Acta Otolaryngol Suppl 2002; (546): 134–41
36. 36. U Bergman A Ostergren AL Gustafson 2002 Differential effects of olfactory toxicants on olfactory regeneration Arch Toxicol 76 2 104 12 11914780 1:CAS:528:DC%2BD38XitFGku7s%3D 10.1007/s00204-002-0321-2 Bergman U, Ostergren A, Gustafson AL, et al. Differential effects of olfactory toxicants on olfactory regeneration. Arch Toxicol 2002; 76(2): 104–12
37. 37. B Oakley DR Riddle 1992 Receptor cell regeneration and connectivity in olfaction and taste Exp Neurol 115 1 50 4 1370222 1:STN:280:DyaK38%2FpslOhuw%3D%3D 10.1016/0014-4886(92)90220-K Oakley B, Riddle DR. Receptor cell regeneration and connectivity in olfaction and taste. Exp Neurol 1992; 115(1): 50–4
38. 38. RB Zain CT Hanks 1989 Morphological changes in taste buds of the fungiform papillae after a single dose of x-ray irradiation in rats Malays J Pathol 11 57 64 2633001 1:STN:280:DyaK3c3hvF2msQ%3D%3D Zain RB, Hanks CT. Morphological changes in taste buds of the fungiform papillae after a single dose of x-ray irradiation in rats. Malays J Pathol 1989; 11: 57–64
39. 39. H Nakamura N Nonomura M Fujiwara 1995 Olfactory disturbances caused by the anti-cancer drug tegafur Eur Arch Otorhinolaryngol 252 1 48 52 7718227 1:STN:280:DyaK2M3jsVejsA%3D%3D 10.1007/BF00171440 Nakamura H, Nonomura N, Fujiwara M, et al. Olfactory disturbances caused by the anti-cancer drug tegafur. Eur Arch Otorhinolaryngol 1995; 252(1): 48–52
40. 40. JB Epstein N Phillips J Parry 2002 Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation Bone Marrow Transplant 30 11 785 92 12439702 1:STN:280:DC%2BD38nnslKksw%3D%3D 10.1038/sj.bmt.1703716 Epstein JB, Phillips N, Parry J, et al. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30(11): 785–92
41. 41. RS Wickham M Rehwaldt C Kefer 1999 Taste changes experienced by patients receiving chemotherapy Oncol Nurs Forum 26 4 697 706 10337648 1:STN:280:DyaK1M3mvF2nsA%3D%3D Wickham RS, Rehwaldt M, Kefer C, et al. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 1999; 26(4): 697–706
42. 42. U Bergström A Giovanetti E Piras 2003 Methimazole-induced damage in the olfactory mucosa: effects on ultrastructure and glutathione levels Tox Path 31 379 87 10.1080/01926230390201101 Bergström U, Giovanetti A, Piras E, et al. Methimazole-induced damage in the olfactory mucosa: effects on ultrastructure and glutathione levels. Tox Path 2003; 31: 379–87
43. 43. P Kiewe S Jovanovic E Thiel 2004 Reversible ageusia after chemotherapy with pegylated liposomal doxorubicin Ann Pharmacother 38 7–8 1212 4 15161947 10.1345/aph.1E116 Kiewe P, Jovanovic S, Thiel E, et al. Reversible ageusia after chemotherapy with pegylated liposomal doxorubicin. Ann Pharmacother 2004; 38(7–8): 1212–4
44. 44. BL Hallman JW Hurst 1953 Loss of taste as a toxic effect of methimazole (tapazole) therapy: report of three cases [letter] J Amer Med Assoc 152 322 1:STN:280:DyaG3s%2FmvFemuw%3D%3D 10.1001/jama.1953.63690040006007d Hallman BL, Hurst JW. Loss of taste as a toxic effect of methimazole (tapazole) therapy: report of three cases [letter]. J Amer Med Assoc 1953; 152: 322
45. 45. RJ McConnell CE Menendez FR Smith 1975 Defects of taste and smell in patients with hypothyroidism Am J Med 59 3 354 64 1163545 1:STN:280:DyaE28%2Fhs1Chug%3D%3D 10.1016/0002-9343(75)90394-0 McConnell RJ, Menendez CE, Smith FR, et al. Defects of taste and smell in patients with hypothyroidism. Am J Med 1975; 59(3): 354–64
46. 46. MB Genter DM Owens HB Carlone 1996 Characterization of olfactory deficits in the rat following administration of 2,6-dichlorobenzonitrile (dichlobenil), 3,3′-iminodipropionitrile, or methimazole Fundam Appl Toxicol 29 1 71 7 8838641 1:CAS:528:DyaK28XlslCisw%3D%3D 10.1006/faat.1996.0007 Genter MB, Owens DM, Carlone HB, et al. Characterization of olfactory deficits in the rat following administration of 2,6-dichlorobenzonitrile (dichlobenil), 3,3′-iminodipropionitrile, or methimazole. Fundam Appl Toxicol 1996; 29(1): 71–7
47. 47. W Xu B Slotnick 1999 Olfaction and peripheral olfactory connections in methimazole-treated rats Behav Brain Res 102 1–2 41 50 10403014 1:CAS:528:DyaK1MXjslOqsb0%3D 10.1016/S0166-4328(99)00004-2 Xu W, Slotnick B. Olfaction and peripheral olfactory connections in methimazole-treated rats. Behav Brain Res 1999; 102(1–2): 41–50
48. 48. J Sitzia C North J Stanley 1997 Side effects of CHOP in the treatment of non-Hodgkins’s lymphoma Cancer Nurs 20 6 430 9 9409065 1:STN:280:DyaK1c%2FntlCmuw%3D%3D 10.1097/00002820-199712000-00007 Sitzia J, North C, Stanley J, et al. Side effects of CHOP in the treatment of non-Hodgkins’s lymphoma. Cancer Nurs 1997; 20(6): 430–9
49. 49. GM Brosvic RL Doty MM Rowe 1992 Influences of hypothyroidism on the taste detection performance of rats: a signal detection analysis Behav Neurosci 106 6 992 8 1472298 1:STN:280:DyaK3s7ht1amtQ%3D%3D 10.1037/0735-7044.106.6.992 Brosvic GM, Doty RL, Rowe MM, et al. Influences of hypothyroidism on the taste detection performance of rats: a signal detection analysis. Behav Neurosci 1992; 106(6): 992–8
50. 50. I Boyd 1993 Captopril-induced taste disturbance [letter] Lancet 342 304 8101327 1:STN:280:DyaK3szitlKqtw%3D%3D 10.1016/0140-6736(93)91850-L Boyd I. Captopril-induced taste disturbance [letter]. Lancet 1993; 342: 304
51. 51. J Zervakis BG Graham SS Schiffman 2000 Taste effects of lingual application of cardiovascular medications Physiol Behav 68 3 405 13 10716552 1:CAS:528:DC%2BD3cXht1Ogtrk%3D 10.1016/S0031-9384(99)00208-5 Zervakis J, Graham BG, Schiffman SS. Taste effects of lingual application of cardiovascular medications. Physiol Behav 2000 Jan; 68(3): 405–13
52. 52. JP Griffin 1992 Drug-induced disorders of taste Adverse Drug React Toxicol Rev 11 4 229 39 1489883 1:STN:280:DyaK3s7ksVGmug%3D%3D Griffin JP. Drug-induced disorders of taste. Adverse Drug React Toxicol Rev 1992; 11(4): 229–39
53. 53. R DiBianco 1990 ACE inhibitors in the treatment of heart failure Clin Cardiol 13 VII32 8 2189619 1:STN:280:DyaK3c3mvVynsw%3D%3D DiBianco R. ACE inhibitors in the treatment of heart failure. Clin Cardiol 1990; 13 (6 Suppl. 7): VII32–8
54. 54. I Grosskopf M Rabinovitz M Garty 1984 Persistent captopril-associated taste alteration [letter] Clin Pharm 3 3 235 6375941 1:STN:280:DyaL2c3jsVKquw%3D%3D Grosskopf I, Rabinovitz M, Garty M, et al. Persistent captopril-associated taste alteration [letter]. Clin Pharm 1984; 3(3): 235
55. 55. JJ McNeil A Anderson N Christophidis 1979 Taste loss associated with oral captopril treatment BMJ 2 1555 6 394799 1:STN:280:DyaL3c7jtFGjsQ%3D%3D 10.1136/bmj.2.6204.1555-a McNeil JJ, Anderson A, Christophidis N, et al. Taste loss associated with oral captopril treatment. BMJ 1979; 2: 1555–6
56. 56. D Unnikrishnan P Murakonda TS Dharmarajan 2004 If it is not cough, it must be dysgeusia: differing adverse effects of angio-tensin-converting enzyme inhibitors in the same individual J Am Med Dir Assoc 5 2 107 10 14984622 1:STN:280:DC%2BD2c%2FpsFKjuw%3D%3D 10.1016/S1525-8610(04)70064-X Unnikrishnan D, Murakonda P, Dharmarajan TS. If it is not cough, it must be dysgeusia: differing adverse effects of angio-tensin-converting enzyme inhibitors in the same individual. J Am Med Dir Assoc 2004; 5(2): 107–10
57. 57. M Heeringa PE Van 1998 Reversible dysgeusia attributed to losartan [letter] Ann Intern Med 129 1 72 9653007 1:STN:280:DyaK1c3pvFCitQ%3D%3D Heeringa M, van PE. Reversible dysgeusia attributed to losartan [letter]. Ann Intern Med 1998; 129(1): 72
58. 58. RG Schlienger M Saxer WE Haefeli 1996 Reversible ageusia associated with losartan [letter] Lancet 347 8999 471 2 8618505 1:STN:280:DyaK287ptVaitA%3D%3D 10.1016/S0140-6736(96)90047-1 Schlienger RG, Saxer M, Haefeli WE. Reversible ageusia associated with losartan [letter]. Lancet 1996; 347(8999): 471–2
59. 59. AI Goldberg MC Dunlay CS Sweet 1995 Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydroclorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension Am J Cardiol 75 12 793 5 7717281 1:STN:280:DyaK2M3jtleisw%3D%3D 10.1016/S0002-9149(99)80413-5 Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydroclorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 1995; 75(12): 793–5
60. 60. KL Goa AJ Wagstaff 1996 Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension Drugs 51 5 820 45 8861549 1:CAS:528:DyaK28XjsVehtr8%3D 10.2165/00003495-199651050-00008 Goa KL, Wagstaff AJ. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 1996; 51(5): 820–45
61. 61. JL Levenson K Kennedy 1985 Dysosmia, dysgeusia, and nifedipine Ann Intern Med 102 1 135 6 3966735 1:STN:280:DyaL2M%2FpsFehsg%3D%3D Levenson JL, Kennedy K. Dysosmia, dysgeusia, and nifedipine. Ann Intern Med 1985; 102(1): 135–6
62. 62. J Guggenheimer 2002 Oral manifestations of drug therapy Dent Clin North Am 46 857 68 12436836 10.1016/S0011-8532(02)00024-1 Guggenheimer J. Oral manifestations of drug therapy. Dent Clin North Am 2002; 46: 857–68
63. 63. LJ Appel 2002 The verdict from ALLHAT: thiazide diuretics are the preferred initial therapy for hypertension JAMA 288 23 3039 42 12479770 10.1001/jama.288.23.3039 Appel LJ. The verdict from ALLHAT: thiazide diuretics are the preferred initial therapy for hypertension. JAMA 2002; 288(23): 3039–42
64. 64. MF Roitman IL Bernstein 1999 Amiloride-sensitive sodium signals and salt appetite: multiple gustatory pathways Am J Physiol Regul Integr Comp Physiol 276 6 1732 8 Roitman MF, Bernstein IL. Amiloride-sensitive sodium signals and salt appetite: multiple gustatory pathways. Am J Physiol Regul Integr Comp Physiol 1999; 276(6): 1732–8
65. 65. SD Roper 2007 Signal transduction and information processing in mammalian taste buds Pflugers Arch 454 5 759 76 17468883 1:CAS:528:DC%2BD2sXmvVKnurk%3D 10.1007/s00424-007-0247-x Roper SD. Signal transduction and information processing in mammalian taste buds. Pflugers Arch 2007; 454(5): 759–76
66. 66. KK Anand JR Zuniga 1997 Effect of amiloride on suprathreshold NaCl, LiCl, and KCl salt taste in humans Physiol Behav 62 4 925 9 9284519 1:CAS:528:DyaK2sXlvVKhur8%3D 10.1016/S0031-9384(97)00174-1 Anand KK, Zuniga JR. Effect of amiloride on suprathreshold NaCl, LiCl, and KCl salt taste in humans. Physiol Behav 1997; 62(4): 925–9
67. 67. RD Mattes CM Christensen K Engelman 1988 Effects of therapeutic doses of amiloride and hydrochlorothiazide on taste, saliva, and salt intake in normotensive adults Chem Senses 13 33 44 1:CAS:528:DyaL1cXhs1Wiu7c%3D 10.1093/chemse/13.1.33 Mattes RD, Christensen CM, Engelman K. Effects of therapeutic doses of amiloride and hydrochlorothiazide on taste, saliva, and salt intake in normotensive adults. Chem Senses 1988; 13: 33–44
68. 68. ME McMurdo GL Hutchinson G Lindsay 1990 Taste disturbance with acetazolamide Lancet 336 8724 1190 1 1978045 1:STN:280:DyaK3M%2FktFaqsA%3D%3D 10.1016/0140-6736(90)92803-P McMurdo ME, Hutchinson GL, Lindsay G. Taste disturbance with acetazolamide. Lancet 1990; 336(8724): 1190–1
69. 69. A Leaf WB Schwartz AS Relman 1954 Oral administration of a potent carbonic anhydrase inhibitor (Diamox): I. Changes in electrolyte and acid-base balance N Engl J Med 250 18 759 64 13165895 1:CAS:528:DyaG2cXntlOisA%3D%3D 10.1056/NEJM195405062501803 Leaf A, Schwartz WB, Relman AS. Oral administration of a potent carbonic anhydrase inhibitor (Diamox): I. Changes in electrolyte and acid-base balance. N Engl J Med 1954; 250(18): 759–64
70. 70. WA Kennedy C Laurier D Gautrin 2000 Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids J Clin Epid 53 97 696 701 1:STN:280:DC%2BD3cvhtl2htA%3D%3D 10.1016/S0895-4356(99)00191-2 Kennedy WA, Laurier C, Gautrin D, et al. Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids. J Clin Epid 2000; 53(97): 696–701
71. 71. JC Mitchell FL Counselman 2003 A taste comparison of three different liquid steroid preparations: prednisone, prednisolone, and dexamethasone Acad Emerg Med 10 4 400 3 12670859 10.1111/j.1553-2712.2003.tb01358.x Mitchell JC, Counselman FL. A taste comparison of three different liquid steroid preparations: prednisone, prednisolone, and dexamethasone. Acad Emerg Med 2003; 10(4): 400–3
72. 72. C Bachert T Akkad El 2002 Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis Ann Allergy Asthma Immunol 89 3 292 7 12269650 10.1016/S1081-1206(10)61957-6 Bachert C, El Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2002; 89(3): 292–7
73. 73. TD Regan D Lewis SA Norton 2006 Taste comparison of corticosteroid suspensions J Drugs Dermatol 5 9 835 7 17039647 Regan TD, Lewis D, Norton SA. Taste comparison of corticosteroid suspensions. J Drugs Dermatol 2006; 5(9): 835–7
74. 74. IL Kratskin Y Kimura L Hastings 1999 Chronic dexamethasone treatment potentiates insult to olfactory receptor cells produced by 3-methylindole Brain Res 847 2 240 6 10575093 1:CAS:528:DyaK1MXnsVKms7w%3D 10.1016/S0006-8993(99)02076-4 Kratskin IL, Kimura Y, Hastings L, et al. Chronic dexamethasone treatment potentiates insult to olfactory receptor cells produced by 3-methylindole. Brain Res 1999; 847(2): 240–6
75. 75. SS Schiffman BG Graham MS Suggs 1998 Effect of psychotropic drugs on taste responses in young and elderly persons Ann NY Acad Sci 855 732 7 9929678 1:CAS:528:DyaK1MXmvFWhtw%3D%3D 10.1111/j.1749-6632.1998.tb10652.x Schiffman SS, Graham BG, Suggs MS, et al. Effect of psychotropic drugs on taste responses in young and elderly persons. Ann NY Acad Sci 1998; 855: 732–7
76. 76. SS Schiffman J Zervakis MS Suggs 1999 Effect of medications on taste: example of amitriptyline HC1 Physiol Behav 66 2 183 91 10336142 1:CAS:528:DyaK1MXjtFGmtrg%3D 10.1016/S0031-9384(98)00263-7 Schiffman SS, Zervakis J, Suggs MS, et al. Effect of medications on taste: example of amitriptyline HC1. Physiol Behav 1999; 66(2): 183–91
77. 77. BH Ackerman N Kasbekar 1997 Disturbances of taste and smell induced by drugs Pharmacotherapy 17 482 96 9165552 1:CAS:528:DyaK2sXktFGlurk%3D Ackerman BH, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy 1997; 17: 482–96
78. 78. KD Hunter WS Wilson 1995 The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva Arch Oral Biol 40 11 983 9 8670028 1:CAS:528:DyaK28XmvFSqtQ%3D%3D 10.1016/0003-9969(95)00079-5 Hunter KD, Wilson WS. The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 1995; 40(11): 983–9
79. 79. JA Johnston J Fiedler-Kelly ED Glover 2001 Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation Nicotine Tob Res 3 2 131 40 11403727 1:CAS:528:DC%2BD3MXmtVGqtbo%3D 10.1080/14622200110042852 Johnston JA, Fiedler-Kelly J, Glover ED, et al. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Nicotine Tob Res 2001; 3(2): 131–40
80. 80. KP Padala CK Hinners PR Padala 2007 Mirtazapine therapy for dysgeusia in an elderly patient J Clin Psychiatry 8 178 80 Padala KP, Hinners CK, Padala PR. Mirtazapine therapy for dysgeusia in an elderly patient. J Clin Psychiatry 2007; 8: 178–80
81. 81. MB Scharf PB Roth RA Dominguez 1990 Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in patients with insomnia J Clin Pharmacol 30 5 461 7 1971831 1:STN:280:DyaK3c3ntVCqsw%3D%3D Scharf MB, Roth PB, Dominguez RA, et al. Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in patients with insomnia. J Clin Pharmacol 1990; 30(5): 461–7
82. 82. KC Berridge S Peciña 1995 Benzodiazepines, appetite, and taste palatability Neurosci Biobehav Rev 19 1 121 31 7770192 1:CAS:528:DyaK2MXktl2jsrg%3D 10.1016/0149-7634(94)00026-W Berridge KC, Peciña S. Benzodiazepines, appetite, and taste palatability. Neurosci Biobehav Rev 1995; 19(1): 121–31
83. 83. EE Caldwell P Wallace SP Taylor 2004 Use of an analog task to study effects of diazepam on taste perception, consummatory behaviors, and risk taking in a social context J Gen Psychol 13 2 101 17 10.3200/GENP.131.2.101-117 Caldwell EE, Wallace P, Taylor SP. Use of an analog task to study effects of diazepam on taste perception, consummatory behaviors, and risk taking in a social context. J Gen Psychol 2004; 13(2): 101–17
84. 84. M Abdullahi M Radfar 2005 A review of drug induced oral reactions J Cont Dent Prac 4 1 1 22 Abdullahi M, Radfar M. A review of drug induced oral reactions. J Cont Dent Prac 2005; 4(1): 1–22
85. 85. A Tyssen B Remmerie C Eng 2007 Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability Clin Ther 29 2 290 304 10.1016/j.clinthera.2007.02.014 1:CAS:528:DC%2BD2sXks1GltbY%3D Tyssen A, Remmerie B, Eng C, et al. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability. Clin Ther 2007; 29(2): 290–304
86. 86. B Bressler 1980 An unusual side-effect of lithium Psychosomatics 21 8 688 9 7208774 1:STN:280:DyaL3M7ltFGlsQ%3D%3D Bressler B. An unusual side-effect of lithium. Psychosomatics 1980; 21(8): 688–9
87. 87. P Vestergaard I Poulstrup M Schou 1988 Prospective studies on a lithium cohort: 3. Tremor, weight gain, diarrhea, psychological complaints Acta Psychiat Scand 78 4 434 41 3227963 1:STN:280:DyaL1M7kslyjuw%3D%3D 10.1111/j.1600-0447.1988.tb06363.x Vestergaard P, Poulstrup I, Schou M. Prospective studies on a lithium cohort: 3. Tremor, weight gain, diarrhea, psychological complaints. Acta Psychiat Scand 1988; 78(4): 434–41
88. 88. JE Duffield 1973 Side effects of lithium carbonate [letter] BMJ 1 5851 491 4689864 1:STN:280:DyaE3s7jt1emsg%3D%3D 10.1136/bmj.1.5851.491-a Duffield JE. Side effects of lithium carbonate [letter]. BMJ 1973; 1(5851): 491
89. 89. JM Himmelhoch I Hanin 1974 Letter: Side effects of lithium carbonate BMJ 4 5938 233 4420067 1:CAS:528:DyaE2MXotVOlsw%3D%3D 10.1136/bmj.4.5938.233 Himmelhoch JM, Hanin I. Letter: Side effects of lithium carbonate. BMJ 1974; 4(5938): 233
90. 90. KD Grupta JW Jefferson 1980 Lithium and “accidentally” induced food aversion [letter] J Clin Psychiatry 41 10 364 7430080 1:STN:280:DyaL3M%2Fks1OgtA%3D%3D Grupta KD, Jefferson JW. Lithium and “accidentally” induced food aversion [letter]. J Clin Psychiatry 1980; 41(10): 364
91. 91. SM Mizielinska 2007 Ion channels in epilepsy Biochem Soc Trans 35 1077 9 17956283 1:CAS:528:DC%2BD2sXht1eru73J 10.1042/BST0351077 Mizielinska SM. Ion channels in epilepsy. Biochem Soc Trans 2007; 35 (Pt 5): 1077–9
92. 92. F Onat C Ozkara 2004 Adverse effects of new antiepileptic drugs Drugs Today 40 4 325 42 15190386 1:CAS:528:DC%2BD2cXlsVCktLk%3D 10.1358/dot.2004.40.4.820079 Onat F, Ozkara C. Adverse effects of new antiepileptic drugs. Drugs Today 2004; 40(4): 325–42
93. 93. JA Zeller J Machetanz C Kessler 1998 Ageusia as an adverse effect of phenytoin treatment Lancet 352 68 10.1016/S0140-6736(05)79553-2 Zeller JA, Machetanz J, Kessler C. Ageusia as an adverse effect of phenytoin treatment. Lancet 1998; 352: 68
94. 94. JL Brandes JR Saper M Diamond 2004 Topiramate for migraine prevention: a randomized controlled trial JAMA 291 8 965 73 14982912 1:CAS:528:DC%2BD2cXhs1ejtbc%3D 10.1001/jama.291.8.965 Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004; 291(8): 965–73
95. 95. S Silberstein E Loder G Forder 2006 The impact of migraine on daily activities: effect of topiramate compared to placebo Curr Med Res Opin 22 1021 9 16846536 1:CAS:528:DC%2BD28XnsFGhsb8%3D 10.1185/030079906X104731 Silberstein S, Loder E, Forder G, et al. The impact of migraine on daily activities: effect of topiramate compared to placebo. Curr Med Res Opin 2006; 22: 1021–9
96. 96. JR Storey CS Calder DE Hart 2001 Topiramate in migraine prevention: a double-blind, placebo-controlled study Headache 41 10 968 75 11903524 1:STN:280:DC%2BD387mvFymtw%3D%3D 10.1046/j.1526-4610.2001.01190.x Storey JR, Calder CS, Hart DE, et al. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001; 41(10): 968–75
97. 97. Y Nakazato K Imai T Abe 2006 Unpleasant sweet taste: a symptom of SIADH caused by lung cancer J Neurol Neurosurg Psychiat 77 3 405 6 16484655 1:STN:280:DC%2BD28%2FpslGisQ%3D%3D 10.1136/jnnp.2005.073726 Nakazato Y, Imai K, Abe T, et al. Unpleasant sweet taste: a symptom of SIADH caused by lung cancer. J Neurol Neurosurg Psychiat 2006; 77(3): 405–6
98. 98. H Panayiotou SC Small JH Hunter 1995 Sweet taste (dysgeusia). The first symptom of hyponatremia in small cell carcinoma of the lung Arch Intern Med 155 12 1325 8 7778965 1:STN:280:DyaK2M3pslyqtw%3D%3D 10.1001/archinte.1995.00430120117014 Panayiotou H, Small SC, Hunter JH, et al. Sweet taste (dysgeusia). The first symptom of hyponatremia in small cell carcinoma of the lung. Arch Intern Med 1995; 155(12): 1325–8
99. 99. RI Marshall PM Bartold 1999 A clinical review of drug-induced gingival overgrowths Aust Dent J 44 219 32 10687229 1:STN:280:DC%2BD3c7ltFyntw%3D%3D 10.1111/j.1834-7819.1999.tb00224.x Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowths. Aust Dent J 1999; 44: 219–32
100. 100. F Mata 1963 Effect of dextro-amphetamine on bitter taste threshold J Neuropsychol 4 315 20 1:STN:280:DyaF2c%2FgsFCitw%3D%3D Mata F. Effect of dextro-amphetamine on bitter taste threshold. J Neuropsychol 1963; 4: 315–20
101. 101. T Saini PC Edwards NS Kimmes 2005 Etiology of xerostomia and dental caries among methamphetamine abusers Oral Health Prev Dent 3 3 189 95 16355653 Saini T, Edwards PC, Kimmes NS, et al. Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev Dent 2005; 3(3): 189–95
102. 102. RL Doty M Ferguson-Segall 1987 Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis Psychopharmacology 93 1 87 93 2819927 1:CAS:528:DyaL2sXlsVOhtr4%3D 10.1007/BF02439592 Doty RL, Ferguson-Segall M. Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis. Psychopharmacology 1987; 93(1): 87–93
103. 103. RL Doty C Li R Bagla 1998 SKF 38393 enhances odor detection performance Psychopharmacology 136 1 75 82 9537685 1:CAS:528:DyaK1cXhslelt7k%3D 10.1007/s002130050541 Doty RL, Li C, Bagla R, et al. SKF 38393 enhances odor detection performance. Psychopharmacology 1998; 136(1): 75–82
104. 104. RL Doty JM Risser 1989 Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration Psychopharmacology 98 3 310 5 2568654 1:CAS:528:DyaL1MXkslSrsbc%3D 10.1007/BF00451680 Doty RL, Risser JM. Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology 1989; 98(3): 310–5
105. 105. AD Krystal JK Walsh E Laska 2003 Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia Sleep 26 7 793 9 14655910 Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26(7): 793–9
106. 106. PH Enghusen S Loft JR Andersen 1992 Disulfiram therapy — adverse drug reactions and interactions Acta Psychiatr Scand Suppl. 369 59 65 Enghusen PH, Loft S, Andersen JR, et al. Disulfiram therapy — adverse drug reactions and interactions. Acta Psychiatr Scand Suppl. 1992; 369: 59–65
107. 107. M Fantino J Hosotte M Apfelbaum 1986 An opioid antagonist, naltrexone, reduces preference for sucrose in humans Am J Physiol 251 1 R91 6 3728712 1:CAS:528:DyaL28XltVyqtr0%3D Fantino M, Hosotte J, Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol 1986; 251(1): R91–6
108. 108. M Bertino GK Beauchamp K Engelman 1991 Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans Am J Physiol 261 R59 63 1858956 1:CAS:528:DyaK3MXltVGqtrw%3D Bertino M, Beauchamp GK, Engelman K. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol 1991 Jul; 261 (1 Pt 2): R59–63
109. 109. JM Komorowski A Komorowska 1986 Naloxone modulates gustatory perception, but not insulin and c-peptide release, in shamfed human-subjects Int J Obes 10 2 83 9 3522452 1:CAS:528:DyaL28Xlt1Orsr0%3D Komorowski JM, Komorowska A. Naloxone modulates gustatory perception, but not insulin and c-peptide release, in shamfed human-subjects. Int J Obes 1986; 10(2): 83–9
110. 110. BA Gaskell 1990 Nonneoplastic changes in the olfactory epithelium: experimental studies Environ Health Perspect 85 275 89 2200667 1:STN:280:DyaK3czksF2jsg%3D%3D 10.2307/3430689 Gaskell BA. Nonneoplastic changes in the olfactory epithelium: experimental studies. Environ Health Perspect 1990; 85: 275–89
111. 111. CJ Reed 1993 Drug metabolism in the nasal cavity: relevance to toxicology Drug Metab Rev 25 1–2 173 205 8449146 1:CAS:528:DyaK3sXktVSju74%3D 10.3109/03602539308993975 Reed CJ. Drug metabolism in the nasal cavity: relevance to toxicology. Drug Metab Rev 1993; 25(1–2): 173–205
112. 112. RE Frye BS Schwartz RL Doty 1990 Dose-related effects of cigarette smoking on olfactory function JAMA 263 9 1233 6 2304239 1:STN:280:DyaK3c7ls1Krtg%3D%3D 10.1001/jama.1990.03440090067028 Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA 1990; 263(9): 1233–6
113. 113. DH Matulionis 1974 Ultrastructure of olfactory epithelia in mice after smoke exposure Ann Otolaryngol 83 192 201 1:STN:280:DyaE2c7isVKqug%3D%3D Matulionis DH. Ultrastructure of olfactory epithelia in mice after smoke exposure. Ann Otolaryngol 1974; 83: 192–201
114. 114. SJ Patel AD Bollhoefer RL Doty 2004 Influences of ethanol ingestion on olfactory function in humans Psychopharmacology 171 4 429 34 14508636 1:CAS:528:DC%2BD2cXmtlGhsA%3D%3D 10.1007/s00213-003-1612-x Patel SJ, Bollhoefer AD, Doty RL. Influences of ethanol ingestion on olfactory function in humans. Psychopharmacology 2004; 171(4): 429–34
115. 115. RG Mair WJ McEntee RL Doty 1983 Olfactory perception in Korsakoff s psychosis: correlation with brain noradrenergic activity Neurology 33 2 64 5 Mair RG, McEntee WJ, Doty RL. Olfactory perception in Korsakoff s psychosis: correlation with brain noradrenergic activity. Neurology 1983; 33 Suppl. 2: 64–5
116. 116. J Vent AM Robinson MJ Gentry-Nielsen 2004 Pathology of the olfactory epithelium: smoking and ethanol exposure Laryngoscope 114 8 1383 8 15280712 1:STN:280:DC%2BD2cvgtVSrug%3D%3D 10.1097/00005537-200408000-00012 Vent J, Robinson AM, Gentry-Nielsen MJ, et al. Pathology of the olfactory epithelium: smoking and ethanol exposure. Laryngoscope 2004; 114(8): 1383–8
117. 117. C Murray N Solish 2003 Metallic taste: an unusual reaction to botulinum toxin A Dermatol Surg 29 562 3 12752530 10.1046/j.1524-4725.2003.29131.x Murray C, Solish N. Metallic taste: an unusual reaction to botulinum toxin A. Dermatol Surg 2003; 29: 562–3
118. 118. ID Mandel 1989 The role of saliva in maintaining oral homeostasis J Am Dent Assoc 119 2 298 304 2671090 1:STN:280:DyaL1MzmtVamsw%3D%3D Mandel ID. The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 1989; 119(2): 298–304
119. 119. I Sarinopoulos GE Dixon SJ Short 2006 Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo Brain Behav Immun 20 2 120 32 16472720 10.1016/j.bbi.2005.11.006 Sarinopoulos I, Dixon GE, Short SJ, et al. Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain Behav Immun 2006; 20(2): 120–32
120. 120. JI Glendinning 1994 Is the bitter rejection response always adaptive? Physiol Behav 56 6 1217 27 7878094 1:CAS:528:DyaK2MXitlOgs70%3D 10.1016/0031-9384(94)90369-7 Glendinning JI. Is the bitter rejection response always adaptive? Physiol Behav 1994; 56(6): 1217–27
121. 121. A Drewnowski 2001 The science and complexity of bitter taste Nutr Rev 59 6 163 9 11444592 1:STN:280:DC%2BD3MzptVaitA%3D%3D 10.1111/j.1753-4887.2001.tb07007.x Drewnowski A. The science and complexity of bitter taste. Nutr Rev 2001; 59(6): 163–9
122. 122. RD Mattes 1994 Influences on acceptance of bitter foods and beverages Physiol Behav 56 6 1229 36 7878095 1:CAS:528:DyaK2MXitlOgs7o%3D 10.1016/0031-9384(94)90370-0 Mattes RD. Influences on acceptance of bitter foods and beverages. Physiol Behav 1994; 56(6): 1229–36
123. 123. DG Liem GC De 2004 Sweet and sour preferences in young children and adults: role of repeated exposure Physiol Behav 83 3 421 9 15581664 1:CAS:528:DC%2BD2cXhtVCltbfL 10.1016/j.physbeh.2004.08.028 Liem DG, De GC. Sweet and sour preferences in young children and adults: role of repeated exposure. Physiol Behav 2004; 83(3): 421–9
124. 124. DG Liem RP Bogers PC Dagnelie 2006 Fruit consumption of boys (8–11 years) is related to preferences for sour taste Appetite 46 1 93 6 16360976 10.1016/j.appet.2005.11.002 Liem DG, Bogers RP, Dagnelie PC, et al. Fruit consumption of boys (8–11 years) is related to preferences for sour taste. Appetite 2006; 46(1): 93–6